Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Yanina Balabanova
Discontinuation of Non-Vitamin K Antagonist Oral Anticoagulants in Patients With Non-Valvular Atrial Fibrillation: A Population-Based Cohort Study Using Primary Care Data From the Health Improvement Network in the UK
BMJ Open
Medicine
Rates of Latent Tuberculosis in Health Care Staff in Russia
PLoS Medicine
Biochemistry
Biotechnology
Molecular Biology
Cell Biology
Medicine
Related publications
Correction: Discontinuation of Non-Vitamin K Antagonist Oral Anticoagulants in Patients With Non-Valvular Atrial Fibrillation: A Population-Based Cohort Study Using Primary Care Data From the Health Improvement Network in the UK
BMJ Open
Medicine
Impact of Non-Vitamin K Antagonist Oral Anticoagulants on Intracranial Bleeding in Asian Patients With Non-Valvular Atrial Fibrillation
Circulation Journal
Medicine
Cardiovascular Medicine
Cardiology
Comparative Effectiveness and Safety of Non-Vitamin K Antagonist Oral Anticoagulants and Warfarin in Patients With Atrial Fibrillation: Propensity Weighted Nationwide Cohort Study
British Medical Journal
Medicine
Comparative Effectiveness of Novel Oral Anticoagulants in UK Patients With Non-Valvular Atrial Fibrillation and Chronic Kidney Disease: A Matched Cohort Study
BMJ Open
Medicine
Overview of the Non-Vitamin K Oral Anticoagulants for Atrial Fibrillation
Therapeutic Advances in Cardiovascular Disease
Cardiovascular Medicine
Pharmacology
Cardiology
Prm20 - Clinical Effectiveness and Safety of Standard-Dose and Low-Dose Non-Vitamin K Antagonist Oral Anticoagulants in Patients With Nonvalvular Atrial Fibrillation: A Nationwide Population-Based Cohort Study
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
The Comparison of Non-Vitamin K Antagonist Oral Anticoagulants Versus Well-Managed Warfarin With a Lower INR Target of 1.5 to 2.5 in Asians Patients With Non-Valvular Atrial Fibrillation
PLoS ONE
Multidisciplinary
Long-Term Vitamin K Antagonists Treatment Patterns of Non-Valvular Atrial Fibrillation (NVAF): A Population-Based Cohort Study
BMC Cardiovascular Disorders
Cardiovascular Medicine
Cardiology
Healthcare Costs of Stroke and Major Bleeding in Patients With Atrial Fibrillation Treated With Non–vitamin K Antagonist Oral Anticoagulants
Journal of Medical Economics
Health Policy
